Volanesorsen

volanesorsen · Akcea Therapeutics (Ionis subsidiary)

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Volanesorsen, covering 2021-08-26 to 2025-12-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen [Phase 3]

See pricing